| David Michael Quinn, MD | |
|
45 Reade Pl, Poughkeepsie, NY 12601 | |
| (845) 454-8500 | |
| Not Available |
| Full Name | David Michael Quinn |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 27 Years |
| Location | 45 Reade Pl, Poughkeepsie, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871557405 | NPI | - | NPPES |
| 04107920 | Medicaid | NY |
| Facility Name | Location | Facility Type |
|---|---|---|
| Vassar Brothers Medical Center | Poughkeepsie, NY | Hospital |
| Northern Dutchess Hospital | Rhinebeck, NY | Hospital |
| Danbury Hospital | Danbury, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nuvance Health Medical Practice, Pc | 1658468442 | 441 |
| Nuvance Health Medical Practice, Pc | 1658468442 | 441 |
| Nuvance Health Medical Practice Ct Inc | 4789597691 | 648 |
News Archive
Bone marrow transplant (BMT) researchers at The Medical College of Wisconsin Cancer Center in Milwaukee may have found a mechanism that could preserve the leukemia-killing effects of a transplant graft, while limiting the damage donor immune cells might do to the recipient host's vital organs.
Enzon Pharmaceuticals, Inc. today announced that, in light of evolving standards of care for the treatment of metastatic colorectal cancer (mCRC), the Company will discontinue its PEG-SN38 (EZN-2208) clinical program in this disease, following conclusion of its Phase II study.
For adult patients with brainstem high-grade gliomas - one of the rarest and deadliest forms of brain cancer - surgically removing the entire tumor may add many months or potentially years of survival beyond that offered by radiation and chemotherapy, according to results of a medical records study led by researchers at the Johns Hopkins Kimmel Cancer Center.
athenahealth, Inc., a leading provider of web-based practice management, electronic health record (EHR), and patient communication services to medical groups, today announced financial and operational results for the second quarter of fiscal year 2010. The Company will conduct a conference call on Friday, July 23, 2010, at 8:00 a.m. Eastern Time to discuss these results and management's outlook for future financial and operational performance.
A group-based, holistic, mind-body intervention was equally effective in treating persistent fatigue and improving quality of life for breast cancer survivors, regardless of their race.
› Verified 8 days ago
| Entity Name | Nuvance Health Medical Practice, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437358033 PECOS PAC ID: 1658468442 Enrollment ID: O20071025000436 |
News Archive
Bone marrow transplant (BMT) researchers at The Medical College of Wisconsin Cancer Center in Milwaukee may have found a mechanism that could preserve the leukemia-killing effects of a transplant graft, while limiting the damage donor immune cells might do to the recipient host's vital organs.
Enzon Pharmaceuticals, Inc. today announced that, in light of evolving standards of care for the treatment of metastatic colorectal cancer (mCRC), the Company will discontinue its PEG-SN38 (EZN-2208) clinical program in this disease, following conclusion of its Phase II study.
For adult patients with brainstem high-grade gliomas - one of the rarest and deadliest forms of brain cancer - surgically removing the entire tumor may add many months or potentially years of survival beyond that offered by radiation and chemotherapy, according to results of a medical records study led by researchers at the Johns Hopkins Kimmel Cancer Center.
athenahealth, Inc., a leading provider of web-based practice management, electronic health record (EHR), and patient communication services to medical groups, today announced financial and operational results for the second quarter of fiscal year 2010. The Company will conduct a conference call on Friday, July 23, 2010, at 8:00 a.m. Eastern Time to discuss these results and management's outlook for future financial and operational performance.
A group-based, holistic, mind-body intervention was equally effective in treating persistent fatigue and improving quality of life for breast cancer survivors, regardless of their race.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Michael Quinn, MD 1351 Route 55 Ste 200, Lagrangeville, NY 12540-5128 Ph: (845) 475-9661 | David Michael Quinn, MD 45 Reade Pl, Poughkeepsie, NY 12601 Ph: (845) 454-8500 |
News Archive
Bone marrow transplant (BMT) researchers at The Medical College of Wisconsin Cancer Center in Milwaukee may have found a mechanism that could preserve the leukemia-killing effects of a transplant graft, while limiting the damage donor immune cells might do to the recipient host's vital organs.
Enzon Pharmaceuticals, Inc. today announced that, in light of evolving standards of care for the treatment of metastatic colorectal cancer (mCRC), the Company will discontinue its PEG-SN38 (EZN-2208) clinical program in this disease, following conclusion of its Phase II study.
For adult patients with brainstem high-grade gliomas - one of the rarest and deadliest forms of brain cancer - surgically removing the entire tumor may add many months or potentially years of survival beyond that offered by radiation and chemotherapy, according to results of a medical records study led by researchers at the Johns Hopkins Kimmel Cancer Center.
athenahealth, Inc., a leading provider of web-based practice management, electronic health record (EHR), and patient communication services to medical groups, today announced financial and operational results for the second quarter of fiscal year 2010. The Company will conduct a conference call on Friday, July 23, 2010, at 8:00 a.m. Eastern Time to discuss these results and management's outlook for future financial and operational performance.
A group-based, holistic, mind-body intervention was equally effective in treating persistent fatigue and improving quality of life for breast cancer survivors, regardless of their race.
› Verified 8 days ago
Dr. Harish Kumar Goli, M.D Pathology Medicare: Accepting Medicare Assignments Practice Location: 241 North Rd, Poughkeepsie, NY 12601 Phone: 914-909-9018 | |
Dr. James Sharp, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 45 Reade Pl, Poughkeepsie, NY 12601 Phone: 845-431-5618 | |
Dr. Ryan Mcknight, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 45 Reade Pl, Vassar Brothers Medical Center, Department Of Pathology, Poughkeepsie, NY 12601 Phone: 845-437-3109 | |
Sutini Ngadiman, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 45 Reade Place, Vassar Brothers Medical Center, Poughkeepsie, NY 12601 Phone: 845-483-6447 | |
Sukyoun Robert Paik, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 45 Reade Pl, Poughkeepsie, NY 12601 Phone: 845-431-5618 Fax: 845-437-3170 | |
Dr. Kari B. Reiber, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 85 Civic Center Plz Ste 106, Poughkeepsie, NY 12601 Phone: 845-486-3432 | |
Dr. Stephanie Rian Schreiner, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 45 Reade Pl, Poughkeepsie, NY 12601 Phone: 845-483-6447 Fax: 845-437-3170 |